Evidence map›Paper›PMID 42043573›Full record

ArticleActa neuropathologica2026

A novel BEND2 monoclonal antibody enables highly specific immunohistochemical diagnosis of BEND2-fusion astroblastomas.

Qianqian Sun, Yixing Shi, Leiming Wang, Lin Bai, Wanming Hu, Yuqiao Xu, Yueshan Piao, Xueling Qi, Jiang Liu, Hongzhi Guan and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qianqian SunState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Yixing ShiBeijing Institute for Brain Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 102206, China.
Leiming Wang *Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. wangleiming0918@163.com.
Lin BaiDepartment of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Wanming HuDepartment of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, 510000, China.
Yuqiao XuDepartment of Pathology, The Basic Medicine Science and the First Affiliated Hospital of the Air Force Medical University, Xi'an, 710032, Shaan Xi Province, China.
Yueshan PiaoDepartment of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Xueling QiDepartment of Pathology, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China.
Jiang LiuState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
Hongzhi GuanDepartment of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Wei ShiBeijing Institute for Brain Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 102206, China. shiwei@cibr.ac.cn.
Yang YuState Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. yuy@ibp.ac.cn.

Funding

Beijing Natural Science Foundation 7264305Beijing Nova Program Z20110000682014Beijing Nova Program Z211100002121041, 20230484485National Natural Science Foundation of China 32170550National Natural Science Foundation of China 32471041
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.